Pharming (PHAR) Interest & Investment Income (2021 - 2026)
Powered by 
Analysis
Pharming (PHAR) Interest & Investment Income (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.74 Bn | 130.89 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.52 Bn | 77.52 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.04 Bn | 52.91 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.98 Bn | 34.88 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.46 Bn | 32.15 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Pharming | 794.84 Mn | 635.34 Mn | 141.47 Mn | 1.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.72 Mn |
| Mar 31, 2026 | 543,000.00 |
| Dec 31, 2025 | -13.62 Mn |
| Sep 30, 2025 | 1.72 Mn |
| Mar 31, 2025 | -4.49 Mn |
| Dec 31, 2024 | 1.89 Mn |
| Sep 30, 2024 | -2.15 Mn |
| Jun 30, 2024 | 3.58 Mn |
| Mar 31, 2024 | 223,000.00 |
| Dec 31, 2023 | -6.34 Mn |
| Sep 30, 2023 | 1.88 Mn |
| Jun 30, 2023 | -4.46 Mn |
| Mar 31, 2023 | -2.67 Mn |
| Mar 31, 2022 | 1.80 Mn |
| Mar 31, 2021 | 6.60 Mn |